United States News
See other United States News Articles
Title: DEA Slapped in Face: American Epilepsy Society Admits Marijuana is an Effective Cure for Seizures
Source:
Counter Current News/American Epilepsy Society
URL Source: http://countercurrentnews.com/2017/ ... eizures-in-epileptic-children/
Published: Jan 11, 2017
Author: Staff
Post Date: 2017-01-11 11:18:08 by Deckard
Keywords: None
Views: 1789
Comments: 15
As the United States Drug Enforcement Agency (DEA) continues to display its arrogance, refusing to remove marijuana from schedule 1 of the Control Substance Act (CSA), thanks to certified professional bodies in the country, more and more details on medical efficacy of the plant is being revealed. On August 11, 2016 the DEA turned down two petitions. One was from the governors of Rhode Island and Washington, and the other from a resident of New Mexico, requesting that marijuana be removed from Schedule I of the CSA. The removal from schedule I would have ensured that official scientific research is carried on the plant, across the United States. But the DEA still held that marijuana has high abuse potential; no medical use; severe safety concerns; and that there is no available scientific research to prove otherwise. This arrogant DEA response has angered Washington state officials, who are now saying that the state will defy the federal ban to issue licenses to laboratories in the state to grow the marijuana for scientific study. Also, a study conducted recently by two researchers from the University of Georgia shed more light on the medicinal and economic benefits of marijuana. The study, published in the journal Health Affairs, revealed that legalizing marijuana for medicinal purposes has helped the United States save $165.2 million in medical care costs in 2013, alone. To add to the growing body of evidence of medical prowess of marijuana, a medical charity in Illinois – the American Epilepsy Society (AES) – has now announced, that a study it supervised has proven that marijuana is an effective cure for seizures, especially in children. The AES has accepted the study in its online journal. The heartwarming announcement was made at the annual meeting of the AES. It is said the study was the largest ever study showing marijuana is capable of curing seizures. According to statistics, epilepsy affects one in 26 Americans during their lifetime. One-third is said to have a form of the condition that resists treatment or effective management. However, children and young adults are the most vulnerable to this devastating condition. According to the study, Cannabidiol (CBD), a non-psychoactive extract of cannabis, can provide the best option for the treatment of epilepsy, especially in children. During the study, 261 patients were given CBD treatment. The results showed that 45% experienced a significant reduction in seizure frequency, with 9% seizure-free just in three months of CBD being administered. The researcher said, even after the study, some children continued to benefit from the plant. Lead author of the study, Dr Orrin Devinsky said: “In the subsequent periods, which are very encouraging, 9 percent of all patients and 13 percent of those with Dravet Syndrome epilepsy were seizure-free. Many have never been seizure-free before.” In the past, The Free Thought Project has covered many stories of CBD providing miraculous benefits to children suffering from treatment-resistant epileptic seizures. With scientific evidence piling up, it is no longer deniable that cannabis provides a host of medical treatments, including treating seizures. Many commentators in the United States now believe the DEA and the federal government should lift the ban on marijuana, in order to allow more scientific research to be conducted on the plant. “As a practitioner, I have had families move to Colorado, and many tried multiple different products. As a doctor, I often don’t feel like I know which of many factors is contributing to a patient doing better or worse. We absolutely need rigorous, scientific data on this,” Dr Devinsky added. 
Post Comment Private Reply Ignore Thread
Top • Page Up • Full Thread • Page Down • Bottom/Latest
Begin Trace Mode for Comment # 8.
#1. To: Deckard (#0)
radiation give street love ps tolerance you no pss good inevitably not
Quacks? the American Epilepsy Society (AES) – has now announced, that a study it supervised has proven that marijuana is an effective cure for seizures, especially in children. The AES has accepted the study in its online journal.
the American Epilepsy Society (AES) – has now announced, that a study it supervised has proven that marijuana is an effective cure for seizures, especially in children. Yes, you and yours sources are quacks. The study was not of marijuana. The drug Epidiolex contains canabidiol, a non-psychoactive component of marijuana, as your link makes clear. https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/2414222 Efficacy and Safety of Epidiolex (Cannabidiol) in Children and Young Adults with Treatment-Resistant Epilepsy: Update from the Expanded Access Program Content: Rationale: Cannabidiol (CBD) is the most abundant non-psychoactive cannabinoid in the cannabis plant. Animal studies demonstrate anticonvulsant efficacy in multiple species and models. Anecdotal reports suggest efficacy in children with treatment-resistant epilepsies (TRE), including Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS). We report current results in our expanded access treatment program. [...] Conclusions: These results from an uncontrolled study support the animal studies and prior reports showing that CBD may be a promising treatment for TRE and it is generally well-tolerated in doses up to 25mg/kg/day. Epidiolex is now being investigated in randomized controlled studies in DS and LGS. By Andrew Pollack An experimental drug derived from marijuana has succeeded in reducing epileptic seizures in its first major clinical trial, the product’s developer announced on Monday, a finding that could lend credence to the medical marijuana movement. The developer, GW Pharmaceuticals, said the drug, Epidiolex, achieved the main goal of the trial, reducing convulsive seizures when compared with a placebo in patients with Dravet syndrome, a rare form of epilepsy. GW shares more than doubled on Monday. If Epidiolex wins regulatory approval, it would be the first prescription drug in the United States that is extracted from marijuana. The drug is a liquid containing cannabidiol, a component of marijuana that does not make people high. [...] Analysts expect Epidiolex to cost $2,500 to $5,000 a month, which would be more expensive than some of the medical marijuana products, which cost from about $100 to more than $1,000 per month. However, Epidiolex might be covered by insurance, unlike the other products. https://www.scientificamerican.com/article/can-cannabis-treat-epileptic-seizures/ New evidence suggests that a chemical derived from marijuana may be an effective treatment for patients with drug-resistant forms of epilepsy By Diana Kwon on January 22, 2016 [excerpts] Last month Orrin Devinsky, a neurologist at New York University Langone Medical Center, and his colleagues across multiple research centers published the results from the largest study to date of a cannabis-based drug for treatment-resistant epilepsy in The Lancet Neurology. The researchers treated 162 patients with an extract of 99 percent cannabidiol (CBD), a nonpsychoactive chemical in marijuana, and monitored them for 12 weeks. This treatment was given as an add-on to the patients’ existing medications and the trial was open-label (everyone knew what they were getting). The researchers reported the intervention reduced motor seizures at a rate similar to existing drugs (a median of 36.5 percent) and 2 percent of patients became completely seizure free. Additionally, 79 percent of patients reported adverse effects such as sleepiness, diarrhea and fatigue, although only 3 percent dropped out of the study due to adverse events. “I was a little surprised that the overall number of side effects was quite high but it seems like most of them were not enough that the patients had to come off the medication,” says Kevin Chapman, a neurology and pediatric professor at the University of Colorado School of Medicine who was not involved in the study. [...] The other major issue is the possibility of drug interactions—because CBD is a potent liver enzyme inhibitor it can increase the concentration of other drugs in the body. This means that when administered with other compounds, consequent effects on patients may be due to the increased exposure to those other drugs rather than the CBD itself. Despite these limitations, both commentary authors agree the study is an important step in establishing CBD as a safe and effective epilepsy treatment. “This is a first step, and it's great,” Detyniecki says. Despite the large number of adverse events, he says that overall “there were no surprising side effects—we can conclude that CBD appears to be safe in the short term.” [...]
wELCOME BACK ...
#10. To: Gatlin (#8)
wELCOME BACK ... Gatlin rants Good grief! Ratchet mouth returns...
Top • Page Up • Full Thread • Page Down • Bottom/Latest
treats
cancer
bottles
of
radiation
to
you
quacks
alley
whinos
boris
increases
have
good
tolerances
comprehension
health
future
tolerance
creates
toxic
poisonous
dosages
people
die
from
side
effects
from
medications
the
disease
itself
#2. To: BorisY (#1)
you quacks
#6. To: Deckard, BorisY, Gatlin, misterwhite (#2)
Quacks?
(Abst. 3.397), 2015
Authors: Orrin Devinsky, Elizabeth Thiele, Linda Laux, Daniel Friedman, Anup Patel, Judith Bluvstein, Michael Chez, Charuta Joshi, Roberta Cilio, Francis Filloux, Evan Fertig, Angus Wilfong, Paul D. Lyons, Yong Park, Robert Flamini, Matthew Wong, Ian Miller, Eric Marsh Marijuana-Based Drug Found to Reduce Epileptic Seizures
NYT
March 14, 2016 Can Cannabis Treat Epileptic Seizures?
Scientific American
#8. To: nolu chan (#6)
Replies to Comment # 8. Yes, you and yours sources are quacks. ---- nolu chants
End Trace Mode for Comment # 8.
[Home] [Headlines] [Latest Articles] [Latest Comments] [Post] [Mail] [Sign-in] [Setup] [Help] [Register]